Andrew S. Davis is Chief Commercial Officer of Silk Road Medical Inc. Currently has a direct ownership of 0 shares of SILK, which is worth approximately $0. The most recent transaction as insider was on Sep 17, 2024, when has been sold 332,295 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Andrew S. Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 17 2024
SELL
Sale (or disposition) back to the issuer
-
332,295 Reduced 100.0%
0 Common Stock
Sep 17 2024
BUY
Grant, award, or other acquisition
-
42,218 Added 50.0%
42,218 Common Stock
Jul 03 2024
SELL
Open market or private sale
$1,782 $27.0 p/Share
66 Reduced 0.02%
289,707 Common Stock
May 20 2024
BUY
Grant, award, or other acquisition
$14,100 $7.05 p/Share
2,000 Added 0.69%
289,773 Common Stock
Mar 05 2024
SELL
Open market or private sale
$94,108 $17.17 p/Share
5,481 Reduced 1.87%
287,773 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
62,201 Added 17.5%
293,254 Common Stock
Sep 15 2023
BUY
Grant, award, or other acquisition
-
121,519 Added 34.47%
231,053 Common Stock
Aug 03 2023
SELL
Open market or private sale
$145,770 $22.13 p/Share
6,587 Reduced 5.67%
109,534 Common Stock
Jul 06 2023
SELL
Open market or private sale
$2,124 $30.79 p/Share
69 Reduced 0.06%
115,614 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
$13,268 $26.17 p/Share
507 Added 0.43%
116,121 Common Stock
May 01 2023
SELL
Open market or private sale
$300,576 $44.51 p/Share
6,753 Reduced 5.52%
115,683 Common Stock
May 01 2023
BUY
Exercise of conversion of derivative security
$60,034 $8.89 p/Share
6,753 Added 5.23%
122,436 Common Stock
Apr 03 2023
SELL
Open market or private sale
$266,203 $39.42 p/Share
6,753 Reduced 5.52%
115,683 Common Stock
Apr 03 2023
BUY
Exercise of conversion of derivative security
$35,048 $5.19 p/Share
6,753 Added 5.23%
122,436 Common Stock
Mar 06 2023
SELL
Open market or private sale
$184,658 $47.74 p/Share
3,868 Reduced 3.24%
115,683 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
21,346 Added 15.15%
119,551 Common Stock
Mar 01 2023
SELL
Open market or private sale
$324,279 $48.02 p/Share
6,753 Reduced 6.43%
98,205 Common Stock
Mar 01 2023
BUY
Exercise of conversion of derivative security
$31,941 $4.73 p/Share
6,753 Added 6.38%
99,019 Common Stock
Feb 01 2023
SELL
Open market or private sale
$364,999 $54.05 p/Share
6,753 Reduced 6.43%
98,205 Common Stock
Feb 01 2023
BUY
Exercise of conversion of derivative security
$31,941 $4.73 p/Share
6,753 Added 6.05%
104,958 Common Stock
Jan 03 2023
SELL
Open market or private sale
$357,031 $52.87 p/Share
6,753 Reduced 6.43%
98,205 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$21,407 $3.17 p/Share
6,753 Added 6.34%
99,783 Common Stock
Dec 01 2022
SELL
Open market or private sale
$357,909 $53.0 p/Share
6,753 Reduced 6.43%
98,205 Common Stock
Dec 01 2022
BUY
Exercise of conversion of derivative security
$10,332 $1.53 p/Share
6,753 Added 6.18%
102,472 Common Stock
Nov 01 2022
SELL
Open market or private sale
$298,280 $44.17 p/Share
6,753 Reduced 6.43%
98,205 Common Stock
ASD

Andrew S. Davis

Chief Commercial Officer
Sunnyvale, CA

Track Institutional and Insider Activities on SILK

Follow Silk Road Medical Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SILK shares.

Notify only if

Insider Trading

Get notified when an Silk Road Medical Inc insider buys or sells SILK shares.

Notify only if

News

Receive news related to Silk Road Medical Inc

Track Activities on SILK